| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | MHC class I receptor activity | 1.06e-14 | 18 | 98 | 8 | GO:0032393 | |
| GeneOntologyMolecularFunction | inhibitory MHC class I receptor activity | 4.28e-14 | 12 | 98 | 7 | GO:0032396 | |
| GeneOntologyMolecularFunction | MHC class Ib protein binding | 6.09e-13 | 16 | 98 | 7 | GO:0023029 | |
| GeneOntologyMolecularFunction | immune receptor activity | LILRA1 LILRA3 LILRB2 CR1 CR1L LILRB1 KIR3DL3 KIR2DL1 KIR2DL3 KIR2DS5 KIR3DL1 KIR3DS1 LILRA4 | 1.52e-12 | 165 | 98 | 13 | GO:0140375 |
| GeneOntologyMolecularFunction | MHC class Ib receptor activity | 2.65e-12 | 19 | 98 | 7 | GO:0032394 | |
| GeneOntologyMolecularFunction | HLA-B specific inhibitory MHC class I receptor activity | 8.12e-09 | 6 | 98 | 4 | GO:0030109 | |
| GeneOntologyMolecularFunction | MHC protein binding | 1.35e-08 | 58 | 98 | 7 | GO:0042287 | |
| GeneOntologyMolecularFunction | IgM binding | 1.75e-07 | 11 | 98 | 4 | GO:0001791 | |
| GeneOntologyMolecularFunction | HLA-A specific inhibitory MHC class I receptor activity | 1.14e-06 | 5 | 98 | 3 | GO:0030107 | |
| GeneOntologyMolecularFunction | MHC class Ib protein complex binding | 3.96e-06 | 7 | 98 | 3 | GO:0023025 | |
| GeneOntologyMolecularFunction | complement component C3b receptor activity | 2.38e-05 | 2 | 98 | 2 | GO:0004877 | |
| GeneOntologyMolecularFunction | complement component C4b receptor activity | 2.38e-05 | 2 | 98 | 2 | GO:0001861 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 2.85e-05 | 36 | 98 | 4 | GO:0019865 | |
| GeneOntologyMolecularFunction | complement component C4b binding | 7.13e-05 | 3 | 98 | 2 | GO:0001855 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | VN1R3 LILRA1 LILRA3 LILRB2 KIR2DS2 PTPRU CR1 CR1L LILRB1 KIR3DL3 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS5 OR5L2 KIR3DL1 KIR3DS1 LILRA4 | 9.24e-05 | 1353 | 98 | 18 | GO:0004888 |
| GeneOntologyMolecularFunction | coreceptor activity | 4.35e-04 | 72 | 98 | 4 | GO:0015026 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 5.13e-04 | 32 | 98 | 3 | GO:0042288 | |
| GeneOntologyMolecularFunction | opsonin receptor activity | 6.55e-04 | 8 | 98 | 2 | GO:0001847 | |
| GeneOntologyMolecularFunction | protein phosphatase 1 binding | 6.69e-04 | 35 | 98 | 3 | GO:0008157 | |
| GeneOntologyMolecularFunction | MHC protein complex binding | 1.07e-03 | 41 | 98 | 3 | GO:0023023 | |
| GeneOntologyMolecularFunction | complement component C3b binding | 1.52e-03 | 12 | 98 | 2 | GO:0001851 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 1.60e-03 | 102 | 98 | 4 | GO:0001540 | |
| GeneOntologyMolecularFunction | complement receptor activity | 2.09e-03 | 14 | 98 | 2 | GO:0004875 | |
| GeneOntologyMolecularFunction | SH2 domain binding | 2.13e-03 | 52 | 98 | 3 | GO:0042169 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.35e-03 | 188 | 98 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor | 2.74e-03 | 16 | 98 | 2 | GO:0016641 | |
| GeneOntologyBiologicalProcess | immune response-regulating signaling pathway | LILRA1 LILRA3 LILRB2 RAPGEF1 KIR2DS2 CR1 LILRB1 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 LRRFIP2 LILRA4 | 4.53e-09 | 615 | 98 | 17 | GO:0002764 |
| GeneOntologyBiologicalProcess | regulation of immune response | LILRA1 LILRA3 LILRB2 MKRN2 RAPGEF1 KIR2DS2 CR1 CR1L LILRB1 KIR3DL3 KIR2DL1 KLK5 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 LRRFIP2 LILRA4 | 1.51e-07 | 1085 | 98 | 20 | GO:0050776 |
| GeneOntologyBiologicalProcess | interleukin-10-mediated signaling pathway | 1.54e-07 | 11 | 98 | 4 | GO:0140105 | |
| GeneOntologyBiologicalProcess | negative regulation of hemopoiesis | 1.09e-05 | 159 | 98 | 7 | GO:1903707 | |
| GeneOntologyBiologicalProcess | immune response-inhibiting cell surface receptor signaling pathway | 1.22e-05 | 10 | 98 | 3 | GO:0002767 | |
| GeneOntologyBiologicalProcess | immune response-inhibiting signal transduction | 2.22e-05 | 12 | 98 | 3 | GO:0002765 | |
| GeneOntologyBiologicalProcess | positive regulation of long-term synaptic depression | 3.64e-05 | 14 | 98 | 3 | GO:1900454 | |
| GeneOntologyBiologicalProcess | negative regulation of immune system process | LILRA1 FN1 LILRB2 MKRN2 IL17D EPX CR1 CR1L LILRB1 SLIT2 TMEM131L LILRA4 | 4.46e-05 | 631 | 98 | 12 | GO:0002683 |
| GeneOntologyBiologicalProcess | negative regulation of cell development | 4.69e-05 | 353 | 98 | 9 | GO:0010721 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte differentiation | 8.43e-05 | 151 | 98 | 6 | GO:1902106 | |
| GeneOntologyBiologicalProcess | defense response to nematode | 1.33e-04 | 4 | 98 | 2 | GO:0002215 | |
| GeneOntologyBiologicalProcess | regulation of long-term synaptic depression | 1.72e-04 | 23 | 98 | 3 | GO:1900452 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 1.78e-04 | 59 | 98 | 4 | GO:0045671 | |
| GeneOntologyBiologicalProcess | regulation of cell development | VIM SETD1A LILRA1 FN1 LILRB2 MBD1 IL17D CR1 LILRB1 SLIT2 CLCN2 NCAN TMEM131L GNAS LILRA4 | 1.98e-04 | 1095 | 98 | 15 | GO:0060284 |
| GeneOntologyBiologicalProcess | Fc receptor mediated inhibitory signaling pathway | 2.21e-04 | 5 | 98 | 2 | GO:0002774 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 2.31e-04 | 116 | 98 | 5 | GO:0045670 | |
| GeneOntologyBiologicalProcess | myeloid dendritic cell differentiation | 3.13e-04 | 28 | 98 | 3 | GO:0043011 | |
| GeneOntologyCellularComponent | Fc-epsilon receptor I complex | 5.39e-08 | 9 | 97 | 4 | GO:0032998 | |
| GeneOntologyCellularComponent | Fc receptor complex | 2.10e-07 | 12 | 97 | 4 | GO:0032997 | |
| MousePheno | decreased length of allograft survival | 1.12e-05 | 9 | 73 | 3 | MP:0004752 | |
| MousePheno | enlarged stomach | 2.50e-05 | 33 | 73 | 4 | MP:0003883 | |
| MousePheno | abnormal visual cortex morphology | 7.29e-05 | 16 | 73 | 3 | MP:0000805 | |
| MousePheno | abnormal occipital lobe morphology | 1.05e-04 | 18 | 73 | 3 | MP:0000804 | |
| MousePheno | abnormal dendritic cell differentiation | 1.46e-04 | 20 | 73 | 3 | MP:0008115 | |
| Domain | ig | LILRA1 LILRA3 KIR2DS2 LILRB1 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 LILRA4 SEMA3E | 1.21e-12 | 190 | 98 | 14 | PF00047 |
| Domain | Immunoglobulin | LILRA1 LILRA3 KIR2DS2 LILRB1 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 LILRA4 SEMA3E | 1.21e-12 | 190 | 98 | 14 | IPR013151 |
| Domain | IG | IGSF8 LILRA1 LILRA3 LILRB2 KIR2DS2 PTPRU LILRB1 NCAN KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 LILRA4 SEMA3E | 6.20e-12 | 421 | 98 | 18 | SM00409 |
| Domain | Ig_sub | IGSF8 LILRA1 LILRA3 LILRB2 KIR2DS2 PTPRU LILRB1 NCAN KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 LILRA4 SEMA3E | 6.20e-12 | 421 | 98 | 18 | IPR003599 |
| Domain | Ig-like_fold | IGSF8 LILRA1 LILRA3 FN1 MYCBP2 LILRB2 KIR2DS2 PTPRU LILRB1 NCAN KIR3DL3 FLRT1 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 LILRA4 SEMA3E | 8.21e-11 | 706 | 98 | 21 | IPR013783 |
| Domain | IG_LIKE | IGSF8 LILRA1 LILRA3 LILRB2 KIR2DS2 PTPRU LILRB1 NCAN KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 LILRA4 SEMA3E | 6.68e-10 | 491 | 98 | 17 | PS50835 |
| Domain | Ig-like_dom | IGSF8 LILRA1 LILRA3 LILRB2 KIR2DS2 PTPRU LILRB1 NCAN KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 LILRA4 SEMA3E | 9.64e-10 | 503 | 98 | 17 | IPR007110 |
| Domain | - | IGSF8 LILRA1 LILRA3 FN1 MYCBP2 KIR2DS2 PTPRU LILRB1 NCAN FLRT1 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL1 KIR3DS1 LILRA4 SEMA3E | 9.23e-09 | 663 | 98 | 18 | 2.60.40.10 |
| Domain | A1B_glyco/leuk_Ig-like_rcpt | 2.77e-06 | 6 | 98 | 3 | IPR016332 | |
| Domain | Ig_2 | 5.88e-04 | 73 | 98 | 4 | PF13895 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | LILRA1 LILRA3 LILRB2 KIR2DS2 LILRB1 KIR2DL1 KIR2DL3 KIR2DS1 KIR3DL1 LILRA4 | 8.88e-08 | 190 | 78 | 10 | M8240 |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 5.35e-07 | 88 | 78 | 7 | M16004 | |
| Pathway | WP_SPINAL_CORD_INJURY | 2.89e-05 | 108 | 78 | 6 | MM15954 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 7.52e-05 | 41 | 78 | 4 | M13519 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 1.09e-04 | 137 | 78 | 6 | M5669 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 1.19e-04 | 46 | 78 | 4 | M27151 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 2.22e-04 | 54 | 78 | 4 | MM14871 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 2.02e-20 | 14 | 101 | 9 | 19875891 | |
| Pubmed | Multiple sclerosis associates with LILRA3 deletion in Spanish patients. | LILRA3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 2.02e-20 | 14 | 101 | 9 | 19421224 |
| Pubmed | Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 2.02e-20 | 14 | 101 | 9 | 15896204 |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 5.03e-20 | 15 | 101 | 9 | 20082646 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 5.03e-20 | 15 | 101 | 9 | 19926642 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 5.03e-20 | 15 | 101 | 9 | 20356536 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 5.03e-20 | 15 | 101 | 9 | 20643584 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 5.03e-20 | 15 | 101 | 9 | 19326408 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 1.15e-19 | 16 | 101 | 9 | 19897003 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 1.15e-19 | 16 | 101 | 9 | 19000141 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 1.15e-19 | 16 | 101 | 9 | 20670355 | |
| Pubmed | Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage. | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 1.15e-19 | 16 | 101 | 9 | 19527230 |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 1.15e-19 | 16 | 101 | 9 | 20652381 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 1.15e-19 | 16 | 101 | 9 | 18668235 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 1.15e-19 | 16 | 101 | 9 | 19279038 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 1.15e-19 | 16 | 101 | 9 | 17868255 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 1.15e-19 | 16 | 101 | 9 | 18643961 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 1.15e-19 | 16 | 101 | 9 | 19309280 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 1.15e-19 | 16 | 101 | 9 | 20331834 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 1.15e-19 | 16 | 101 | 9 | 20210919 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 2.43e-19 | 17 | 101 | 9 | 20173792 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 2.43e-19 | 17 | 101 | 9 | 20483367 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 2.43e-19 | 17 | 101 | 9 | 19968064 | |
| Pubmed | [Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese]. | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 2.43e-19 | 17 | 101 | 9 | 19218127 |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 2.43e-19 | 17 | 101 | 9 | 19169284 | |
| Pubmed | Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 2.43e-19 | 17 | 101 | 9 | 20878400 |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 2.43e-19 | 17 | 101 | 9 | 20650299 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 2.43e-19 | 17 | 101 | 9 | 19450876 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 2.43e-19 | 17 | 101 | 9 | 19761533 | |
| Pubmed | Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 4.85e-19 | 18 | 101 | 9 | 19630074 |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 4.85e-19 | 18 | 101 | 9 | 20519398 | |
| Pubmed | Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians. | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 4.85e-19 | 18 | 101 | 9 | 19046302 |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 4.85e-19 | 18 | 101 | 9 | 19846535 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 4.85e-19 | 18 | 101 | 9 | 20580654 | |
| Pubmed | [Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients]. | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 6.24e-19 | 11 | 101 | 8 | 19664392 |
| Pubmed | KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease. | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 9.19e-19 | 19 | 101 | 9 | 18571006 |
| Pubmed | Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil. | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 9.19e-19 | 19 | 101 | 9 | 18778326 |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 9.19e-19 | 19 | 101 | 9 | 20600442 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 9.19e-19 | 19 | 101 | 9 | 18848853 | |
| Pubmed | Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay. | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 1.67e-18 | 20 | 101 | 9 | 20193031 |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 1.87e-18 | 12 | 101 | 8 | 20371502 | |
| Pubmed | Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome. | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 1.87e-18 | 12 | 101 | 8 | 19181658 |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 1.87e-18 | 12 | 101 | 8 | 19936734 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 2.91e-18 | 21 | 101 | 9 | 19861144 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 4.85e-18 | 13 | 101 | 8 | 18687225 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 4.85e-18 | 13 | 101 | 8 | 19934297 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 4.85e-18 | 13 | 101 | 8 | 19120281 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 4.91e-18 | 22 | 101 | 9 | 20492596 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL1 KIR3DS1 | 1.13e-17 | 14 | 101 | 8 | 19489269 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 1.13e-17 | 14 | 101 | 8 | 18945962 | |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 2.41e-17 | 15 | 101 | 8 | 19850842 | |
| Pubmed | Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma. | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 2.41e-17 | 15 | 101 | 8 | 20207982 |
| Pubmed | KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 2.41e-17 | 15 | 101 | 8 | 19493232 | |
| Pubmed | KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations. | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 | 2.41e-17 | 15 | 101 | 8 | 17498266 |
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population]. | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 | 4.81e-17 | 16 | 101 | 8 | 16403292 |
| Pubmed | KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 9.07e-17 | 17 | 101 | 8 | 19032228 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DS1 | 9.07e-17 | 17 | 101 | 8 | 20173784 | |
| Pubmed | Immunogenetic characteristics of patients with autoimmune gastritis. | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 9.73e-17 | 29 | 101 | 9 | 20082482 |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 | 1.63e-16 | 18 | 101 | 8 | 20200544 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL1 KIR3DS1 | 1.63e-16 | 18 | 101 | 8 | 20210918 | |
| Pubmed | 1.68e-16 | 10 | 101 | 7 | 12559621 | ||
| Pubmed | 4.61e-16 | 11 | 101 | 7 | 18830515 | ||
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 4.66e-16 | 20 | 101 | 8 | 20426625 | |
| Pubmed | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 6.76e-16 | 35 | 101 | 9 | 19683555 | |
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia]. | 1.10e-15 | 12 | 101 | 7 | 17490516 | |
| Pubmed | 1.10e-15 | 12 | 101 | 7 | 20137308 | ||
| Pubmed | 1.44e-14 | 8 | 101 | 6 | 18681957 | ||
| Pubmed | 4.30e-14 | 9 | 101 | 6 | 7749980 | ||
| Pubmed | Alternatively spliced forms of human killer inhibitory receptors. | 4.30e-14 | 9 | 101 | 6 | 8662091 | |
| Pubmed | 1.07e-13 | 10 | 101 | 6 | 21206914 | ||
| Pubmed | 1.87e-13 | 5 | 101 | 5 | 16112031 | ||
| Pubmed | 1.87e-13 | 5 | 101 | 5 | 18755860 | ||
| Pubmed | 1.12e-12 | 6 | 101 | 5 | 17882223 | ||
| Pubmed | 3.91e-12 | 7 | 101 | 5 | 14607943 | ||
| Pubmed | Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors. | 3.91e-12 | 7 | 101 | 5 | 11169255 | |
| Pubmed | 3.91e-12 | 7 | 101 | 5 | 9430220 | ||
| Pubmed | KIR haplotype content at the allele level in 77 Northern Irish families. | 1.04e-11 | 8 | 101 | 5 | 17200871 | |
| Pubmed | 1.04e-11 | 8 | 101 | 5 | 15730517 | ||
| Pubmed | 1.04e-11 | 8 | 101 | 5 | 9430221 | ||
| Pubmed | 2.33e-11 | 9 | 101 | 5 | 18340360 | ||
| Pubmed | 6.70e-11 | 4 | 101 | 4 | 19522772 | ||
| Pubmed | 6.70e-11 | 4 | 101 | 4 | 21559424 | ||
| Pubmed | 6.70e-11 | 4 | 101 | 4 | 18269867 | ||
| Pubmed | 6.70e-11 | 4 | 101 | 4 | 26542066 | ||
| Pubmed | HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding. | 6.70e-11 | 4 | 101 | 4 | 21270408 | |
| Pubmed | 3.34e-10 | 5 | 101 | 4 | 16698429 | ||
| Pubmed | 3.34e-10 | 5 | 101 | 4 | 7716543 | ||
| Pubmed | 3.34e-10 | 5 | 101 | 4 | 12121272 | ||
| Pubmed | Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual. | 3.34e-10 | 5 | 101 | 4 | 10424431 | |
| Pubmed | 1.00e-09 | 6 | 101 | 4 | 20528243 | ||
| Pubmed | 2.33e-09 | 7 | 101 | 4 | 12618911 | ||
| Pubmed | Expression of a killer cell receptor-like gene in plastic regions of the central nervous system. | 2.33e-09 | 7 | 101 | 4 | 15748957 | |
| Pubmed | 4.65e-09 | 8 | 101 | 4 | 9548455 | ||
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 4.65e-09 | 8 | 101 | 4 | 12634303 | |
| Pubmed | 4.65e-09 | 8 | 101 | 4 | 20935224 | ||
| Pubmed | 8.35e-09 | 9 | 101 | 4 | 18074414 | ||
| Pubmed | 2.18e-08 | 11 | 101 | 4 | 24052308 | ||
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 29549293 | ||
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 16698433 | ||
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 30696053 | ||
| Interaction | LILRA3 interactions | 9.45e-10 | 11 | 95 | 5 | int:LILRA3 | |
| Interaction | KIR2DL2 interactions | 2.61e-09 | 13 | 95 | 5 | int:KIR2DL2 | |
| Interaction | KIR3DL1 interactions | 3.21e-07 | 13 | 95 | 4 | int:KIR3DL1 | |
| Interaction | KIR3DP1 interactions | 4.05e-07 | 4 | 95 | 3 | int:KIR3DP1 | |
| Interaction | KIR2DS2 interactions | 8.10e-07 | 37 | 95 | 5 | int:KIR2DS2 | |
| Interaction | HLA-C interactions | TSSK6 LILRB2 KIR2DS2 LILRB1 CNNM3 KIR3DL3 TMEM131L KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 | 8.56e-07 | 353 | 95 | 11 | int:HLA-C |
| Interaction | ANKRD20A4P interactions | 2.01e-06 | 6 | 95 | 3 | int:ANKRD20A4P | |
| Interaction | KIR2DS3 interactions | 2.12e-06 | 20 | 95 | 4 | int:KIR2DS3 | |
| Interaction | ANKRD20A2P interactions | 3.50e-06 | 7 | 95 | 3 | int:ANKRD20A2P | |
| Interaction | ANKRD20A1 interactions | 1.63e-05 | 11 | 95 | 3 | int:ANKRD20A1 | |
| Interaction | LILRA1 interactions | 2.20e-05 | 2 | 95 | 2 | int:LILRA1 | |
| Interaction | KIR2DS5 interactions | 5.44e-05 | 16 | 95 | 3 | int:KIR2DS5 | |
| Cytoband | 19q13.4 | LILRA1 LILRA3 LILRB2 KIR2DS2 LILRB1 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 LILRA4 | 2.97e-21 | 79 | 101 | 13 | 19q13.4 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | LILRA1 ODAD1 LILRB2 LILRB1 KIR3DL3 KIR2DL1 KLK5 KIR2DL3 KIR3DL1 LILRA4 | 3.05e-04 | 1192 | 101 | 10 | chr19q13 |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 KIR3DS1 | 3.57e-18 | 18 | 67 | 9 | 620 |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | IGSF8 LILRA1 LILRA3 LILRB2 KIR2DS2 CR1 LILRB1 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 LILRA4 | 1.12e-11 | 394 | 67 | 15 | 471 |
| GeneFamily | CD molecules|Activating leukocyte immunoglobulin like receptors | 9.65e-07 | 6 | 67 | 3 | 1181 | |
| GeneFamily | CD molecules|Inhibitory leukocyte immunoglobulin like receptors | 1.34e-04 | 5 | 67 | 2 | 1182 | |
| GeneFamily | Zinc fingers CXXC-type | 8.72e-04 | 12 | 67 | 2 | 136 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.23e-03 | 57 | 67 | 3 | 1179 | |
| Coexpression | KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE | KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 | 1.45e-11 | 49 | 101 | 8 | M40909 |
| Coexpression | KIM_GLIS2_TARGETS_UP | 2.81e-06 | 102 | 101 | 6 | MM1064 | |
| Coexpression | GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN | 9.12e-06 | 190 | 101 | 7 | M4662 | |
| Coexpression | GSE22886_DC_VS_MONOCYTE_DN | 1.27e-05 | 200 | 101 | 7 | M4472 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE | 4.06e-05 | 426 | 101 | 9 | M41019 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CD16_POS_NK_CELL | 4.34e-05 | 18 | 101 | 3 | M45763 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | 4.94e-05 | 437 | 101 | 9 | M1610 | |
| Coexpression | SOUCEK_MYC_TARGETS | 5.15e-05 | 19 | 101 | 3 | MM1252 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | 6.74e-05 | 455 | 101 | 9 | MM1189 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-CD16+_Monocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.14e-07 | 194 | 96 | 7 | b133d3d198360269cc449a75d34c29be377d91e0 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_C|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.23e-06 | 187 | 96 | 6 | 1e8651e6c547384ace5a66b96c6b24a7f390a7ee | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.33e-06 | 188 | 96 | 6 | 9abd78970bbe4ed03b59a83da63bbd334712f605 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.33e-06 | 188 | 96 | 6 | f7dc29dfec68236883469e848be5db34f5526d6b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.33e-06 | 188 | 96 | 6 | 5ae8ccdd328cf117da1d01ced2c3b7f763a5f1f1 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.76e-06 | 192 | 96 | 6 | 1922b0350d3375e67c314dbce8074e5cf986f2ef | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.76e-06 | 192 | 96 | 6 | 97c197643e59835c6d45dde9e549c9a1b1bb7288 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.76e-06 | 192 | 96 | 6 | a4d161e3d48bc020e687808b352325ef9d1cc1f3 | |
| ToppCell | droplet-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-06 | 193 | 96 | 6 | e55f79bad6888b84b0ad5fccded498b170e3c6dc | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.99e-06 | 194 | 96 | 6 | f9fbb043411546d8c9e0321a64165d411f44aeb7 | |
| ToppCell | 343B-Myeloid-Monocyte|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.11e-06 | 195 | 96 | 6 | 169b4952118ca5ded55de928a1cf08721cdac193 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.11e-06 | 195 | 96 | 6 | 1be9502577267ca2a04656a99d57e3e2f124d92e | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 4.36e-06 | 197 | 96 | 6 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | NS-control-d_0-4-Myeloid-Non-resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.36e-06 | 197 | 96 | 6 | 496a1115071a1be6928786192de49f3adf197dfb | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.62e-06 | 199 | 96 | 6 | ac866ae110967c5867ff4601939b79861d43df54 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.76e-06 | 200 | 96 | 6 | a637281d91e95734ee4f8510b3780e0272b16fda | |
| ToppCell | Sigmoid-(4)_Monocyte|Sigmoid / shred on region, Cell_type, and subtype | 4.76e-06 | 200 | 96 | 6 | 7f3920a0434d5199c6c8f0b3064a305bb0d87b60 | |
| ToppCell | Sigmoid-Monocyte-Monocyte|Sigmoid / Region, Cell class and subclass | 4.76e-06 | 200 | 96 | 6 | 010ca36970cb8894bdbca08779c0ecf56be22fc9 | |
| ToppCell | Sigmoid-Monocyte|Sigmoid / Region, Cell class and subclass | 4.76e-06 | 200 | 96 | 6 | c41bd6ec0f2262fce5cadb37a400d487e6662f49 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.76e-06 | 200 | 96 | 6 | 8872d5fa101d413fb43b4231d476878678543035 | |
| ToppCell | Sigmoid-(4)_Monocyte-(40)_Monocyte|Sigmoid / shred on region, Cell_type, and subtype | 4.76e-06 | 200 | 96 | 6 | 576c0a1098e6a934448705de3673ef798fcf1b26 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.76e-06 | 200 | 96 | 6 | fc061de0db2e8b5ca47f5e2a1e861018e7f1b582 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-05 | 155 | 96 | 5 | e1a20e88b9c0eaf7ca7004acc0eda096d1588563 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.23e-05 | 156 | 96 | 5 | e6798d2b9c2c1fc6525c24f596f25aa85a375651 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_C|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.23e-05 | 156 | 96 | 5 | a1b9e7621b646d354c2ccd850ce6a4fa9ff8a026 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-05 | 167 | 96 | 5 | 805129f887078340b260aa136b0ba19f2bd6ea03 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-05 | 167 | 96 | 5 | 31cf8bf2eb523f6e7e319620648ff37fc09e2601 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-05 | 167 | 96 | 5 | 3acb18428d1d33ad430c2fd031b1a91baee3c01d | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.65e-05 | 173 | 96 | 5 | 79d11f94a8f6a420c18c2fef0da77e9af3204765 | |
| ToppCell | Basal_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.76e-05 | 174 | 96 | 5 | a0060be3940043015dcc49a5157de5541aed24a1 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.41e-05 | 180 | 96 | 5 | ddbab26b05f057bd78b78773381cd447bd2e2726 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-CD8_TRM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.90e-05 | 184 | 96 | 5 | 17ffa0e890960c00a3b5fa33d48caba66c61dbb0 | |
| ToppCell | Control-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 4.90e-05 | 184 | 96 | 5 | c6affa0b12510363258f65e46bf2d47bf4a8e75f | |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 4.90e-05 | 184 | 96 | 5 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.03e-05 | 185 | 96 | 5 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Control-T_cells-NK_cells|Control / group, cell type (main and fine annotations) | 5.03e-05 | 185 | 96 | 5 | 755c0998c729f462399f1d5e88adf4bfae31be30 | |
| ToppCell | IPF-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 5.16e-05 | 186 | 96 | 5 | 962c2dada19185628ead77c32fcb07fa95114247 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.16e-05 | 186 | 96 | 5 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 5.16e-05 | 186 | 96 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease state, Lineage and Cell class | 5.16e-05 | 186 | 96 | 5 | b05c394aa3573ba855abc3066739ca193883b0c3 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.29e-05 | 187 | 96 | 5 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | IPF-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 5.43e-05 | 188 | 96 | 5 | 47bb6caf84f70a1cda7d09803afdfd5182772e66 | |
| ToppCell | IPF-Myeloid-cDC1|IPF / Disease state, Lineage and Cell class | 5.43e-05 | 188 | 96 | 5 | 2331a2bae1383820d598e93aa86c75b101069bac | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.56e-05 | 189 | 96 | 5 | 723c57f278919e8251d56b3d19411f9088319450 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.56e-05 | 189 | 96 | 5 | 960374f5fb278659500a7c948c3068a95dd62eb0 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.70e-05 | 190 | 96 | 5 | 1f890be1ac8613a098b271945f25a58c3c2530ab | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 5.70e-05 | 190 | 96 | 5 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.70e-05 | 190 | 96 | 5 | d7cecf88451f736f8f3f6f4644504cf22846cd6e | |
| ToppCell | (1)_T_cells-(1)_T_CD8_gd|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 5.70e-05 | 190 | 96 | 5 | 268772d2adff34f7175b8474e95b67fd96dc1234 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Non-resident_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.70e-05 | 190 | 96 | 5 | 4fe9654a9b449ef49ca10b973ac4378dab34cb53 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|lymph-node_spleen / Manually curated celltypes from each tissue | 5.85e-05 | 191 | 96 | 5 | f802a4686ecf00e8302047bfe23356f24b266cf8 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.85e-05 | 191 | 96 | 5 | c9f3bdb5c0a90268cab24a0fe4c3a8290fcedeb8 | |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 5.85e-05 | 191 | 96 | 5 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-05 | 191 | 96 | 5 | 47a2afc4102199b4bc76bd01b2967c8016186462 | |
| ToppCell | COPD-Myeloid-cDC1|COPD / Disease state, Lineage and Cell class | 5.99e-05 | 192 | 96 | 5 | bd3d00b094d92463b06023361a71240851a542b8 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo|lymph-node_spleen / Manually curated celltypes from each tissue | 5.99e-05 | 192 | 96 | 5 | 4d72b9264ed62e0c08cde4078061b348253f6989 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.99e-05 | 192 | 96 | 5 | b86476037ddf8904c1d8a6b3763af7242c031cf3 | |
| ToppCell | PND07|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.99e-05 | 192 | 96 | 5 | 8171a60df481195c39a7f740effcae8e4deb6ca7 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 6.14e-05 | 193 | 96 | 5 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | CF-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 6.14e-05 | 193 | 96 | 5 | 7ebf20344a9a154fd2cffa281526867fcf0aded3 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-CD56_bright_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.14e-05 | 193 | 96 | 5 | 46f94a1062b098205e8ce3ed380c0202a4d97678 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-NK|ICU-SEP / Disease, Lineage and Cell Type | 6.14e-05 | 193 | 96 | 5 | f110f86db305e41639087f5b1a2dff103c07adf0 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.30e-05 | 194 | 96 | 5 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-CD16+_Monocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.30e-05 | 194 | 96 | 5 | 1b4a17d58793e8889484fe592dce8ee1e8fe77a9 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 6.30e-05 | 194 | 96 | 5 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.30e-05 | 194 | 96 | 5 | 69cf7c989ac355c459db13f9d4267b55adc3c174 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 6.30e-05 | 194 | 96 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-NK|Leuk-UTI / Disease, Lineage and Cell Type | 6.30e-05 | 194 | 96 | 5 | 36afc4e48d267be3b8aa1e33fad043bcd54c6bc5 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.30e-05 | 194 | 96 | 5 | dfe0ece81922bfd7c6673726d3ea2365cbdb5513 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_dendritic_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.45e-05 | 195 | 96 | 5 | 4387e27d2288fb46a9ed110464542a4aea402358 | |
| ToppCell | Adult-Immune-monocyte-D231|Adult / Lineage, Cell type, age group and donor | 6.45e-05 | 195 | 96 | 5 | ea24da6fea1487acb1e56c28c0649858cc0a12bd | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 6.45e-05 | 195 | 96 | 5 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | NS-critical-d_07-13-Myeloid-Non-resident_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.45e-05 | 195 | 96 | 5 | ee8743d39996bb756f50db32748e8a902d3294b8 | |
| ToppCell | 343B-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.45e-05 | 195 | 96 | 5 | d1ec768573929c717bb6b20ad5f26c4549cfcaed | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.45e-05 | 195 | 96 | 5 | 98b02beafe1d418442e41f85cbf0c7b194fe5957 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.45e-05 | 195 | 96 | 5 | 9ecae6c26a0d0607d101ccf1c38f0b23c5a256a8 | |
| ToppCell | 343B-Myeloid-Monocyte-CD14+_Monocyte|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.45e-05 | 195 | 96 | 5 | b5ee368c97113432fc8fe742654cd538558f327c | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.61e-05 | 196 | 96 | 5 | 646a8d47dddffdfd2d8a62245ea6cd49f9510a1a | |
| ToppCell | distal-Hematologic-OLR1+_Classical_Monocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.61e-05 | 196 | 96 | 5 | 80fc5b9e04ead0b38304dccbe39f66575e2bf203 | |
| ToppCell | Adult-Immune-monocyte|Adult / Lineage, Cell type, age group and donor | 6.61e-05 | 196 | 96 | 5 | 3ef193c5180de3137daf886492e74fc574bc9767 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Neutrophils|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.61e-05 | 196 | 96 | 5 | 376c5a459a484205fbb0db34936e4a6146d1f622 | |
| ToppCell | BL-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.61e-05 | 196 | 96 | 5 | cfbeaabbeeb197f0cf8240a752d1f2995d59d7b7 | |
| ToppCell | Severe-NK|Severe / Disease group and Cell class | 6.61e-05 | 196 | 96 | 5 | 66130d38b67e51e2385de8a89227759fd137999c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.61e-05 | 196 | 96 | 5 | 9b3848dd4256cd6d9a21ef6bfdbd0cb7c0030005 | |
| ToppCell | distal-Hematologic-OLR1+_Classical_Monocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.61e-05 | 196 | 96 | 5 | 3f57216dbc9ef28fca09bbb8805f7c15b03b99e8 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.61e-05 | 196 | 96 | 5 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.61e-05 | 196 | 96 | 5 | 78b28b263deaa43590b38597186222c6447ad25f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.61e-05 | 196 | 96 | 5 | 3e78e307c9c991c1aadc85c61d401431cf75eaec | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.61e-05 | 196 | 96 | 5 | f0566f2ef96584ed6d9247b149218376fb509915 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.77e-05 | 197 | 96 | 5 | 48a8169a4d33c6a68d66bcd936861c75cb4b60ef | |
| ToppCell | PND03-Mesenchymal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.77e-05 | 197 | 96 | 5 | e3053ef8f604b6892c21c03e12612b49d3d30f23 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 6.77e-05 | 197 | 96 | 5 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.77e-05 | 197 | 96 | 5 | 59aa4a31674125ae422450aee45db3ced5c405d3 | |
| ToppCell | Severe-NK|World / Disease group and Cell class | 6.77e-05 | 197 | 96 | 5 | 1e5fb79385657a467c2d9f942d8cafb8ef7826c9 | |
| ToppCell | Children_(3_yrs)-Immune|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.77e-05 | 197 | 96 | 5 | f18807124b91310fcd84238484a80ecdba684679 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.77e-05 | 197 | 96 | 5 | 8b9a88fb671d5c2b25d291c851e2b8a478f2610c | |
| ToppCell | Influenza_Severe-NK|World / Disease group and Cell class | 6.77e-05 | 197 | 96 | 5 | 565d578f7a28a19175d56663bf30c60e0d5e1b22 | |
| ToppCell | Dendritic_cell|World / shred by cell class for turbinate | 6.77e-05 | 197 | 96 | 5 | ab2213e3742f92798922ea318d76328b6ca18b13 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-stromal_related|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.77e-05 | 197 | 96 | 5 | ea9332adf753d7e92f89654320543abb9e6142aa | |
| ToppCell | 343B-Myeloid-Monocyte-CD16+_Monocyte|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.77e-05 | 197 | 96 | 5 | 8d6551e118cfe308088487c6d5171d986f90fb2f | |
| Computational | Neighborhood of IL2RB | 9.82e-05 | 46 | 57 | 4 | GNF2_IL2RB | |
| Drug | D-Au | LILRB1 KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 KIR3DL1 | 1.71e-09 | 77 | 100 | 8 | CID000277822 |
| Drug | Aa1 | 3.13e-09 | 83 | 100 | 8 | CID009549188 | |
| Drug | IL-T | 1.68e-07 | 56 | 100 | 6 | CID000150551 | |
| Drug | Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; HL60; HT_HG-U133A | 2.57e-06 | 197 | 100 | 8 | 2343_DN | |
| Drug | 1xa5 | 3.45e-06 | 93 | 100 | 6 | CID000157684 | |
| Drug | LTC4 (leukotriene C4 | 1.48e-05 | 180 | 100 | 7 | CID000003907 | |
| Drug | 1c88 | 1.99e-05 | 126 | 100 | 6 | CID000444766 | |
| Drug | auramine | 2.89e-05 | 14 | 100 | 3 | CID000010298 | |
| Drug | Idoxuridine [54-42-2]; Up 200; 11.2uM; PC3; HG-U133A | 2.92e-05 | 200 | 100 | 7 | 1899_UP | |
| Drug | Pivmecillinam hydrochloride [32887-03-9]; Up 200; 8.4uM; PC3; HT_HG-U133A | 2.92e-05 | 200 | 100 | 7 | 7312_UP | |
| Drug | AGN 1135 | 3.75e-05 | 141 | 100 | 6 | CID000122316 | |
| Disease | level of killer cell immunoglobulin-like receptor 2DS2 in blood serum | 2.84e-08 | 3 | 91 | 3 | OBA_2042107 | |
| Disease | killer cell immunoglobulin-like receptor 2DS2 measurement | 1.26e-05 | 15 | 91 | 3 | EFO_0801746 | |
| Disease | malaria (is_implicated_in) | 5.48e-05 | 24 | 91 | 3 | DOID:12365 (is_implicated_in) | |
| Disease | blood sedimentation | 1.96e-04 | 7 | 91 | 2 | EFO_0004304 | |
| Disease | anxiety, vitamin D measurement | 1.96e-04 | 7 | 91 | 2 | EFO_0004631, EFO_0005230 | |
| Disease | acquired immunodeficiency syndrome (is_implicated_in) | 3.34e-04 | 9 | 91 | 2 | DOID:635 (is_implicated_in) | |
| Disease | interleukin 7 measurement | 3.67e-04 | 45 | 91 | 3 | EFO_0008189 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 2 measurement | 5.08e-04 | 11 | 91 | 2 | EFO_0008209 | |
| Disease | Mental Retardation, Psychosocial | 9.18e-04 | 139 | 91 | 4 | C0025363 | |
| Disease | Profound Mental Retardation | 9.18e-04 | 139 | 91 | 4 | C0020796 | |
| Disease | Mental deficiency | 9.18e-04 | 139 | 91 | 4 | C0917816 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 1 measurement | 9.62e-04 | 15 | 91 | 2 | EFO_0008208 | |
| Disease | response to ketamine | 1.28e-03 | 69 | 91 | 3 | EFO_0009748 | |
| Disease | anthropometric measurement | 1.84e-03 | 168 | 91 | 4 | EFO_0004302 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.96e-03 | 80 | 91 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | nephrosis (biomarker_via_orthology) | 2.09e-03 | 22 | 91 | 2 | DOID:2527 (biomarker_via_orthology) | |
| Disease | cup-to-disc ratio measurement | 2.17e-03 | 430 | 91 | 6 | EFO_0006939 | |
| Disease | Ureteral obstruction | 2.48e-03 | 24 | 91 | 2 | C0041956 | |
| Disease | aortic root size | 2.91e-03 | 26 | 91 | 2 | EFO_0005037 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GSIDHVYTGSGYRIR | 16 | Q5TYW2 | |
| ISFRGAYHGCSPYTL | 191 | Q9BYV1 | |
| GSIDHVYTGSGYRIR | 16 | Q5CZ79 | |
| GSIDHVYTGSGYRIR | 16 | Q4UJ75 | |
| RYGEDYSRSRGSPSS | 171 | Q9H201 | |
| CVDRAGYHYTSTPER | 336 | Q9NUG4 | |
| RSPSYSRHSSYERGG | 366 | Q14004 | |
| AYGTRCRYDHTRPSA | 46 | Q9H000 | |
| RTITSSYYRGAHGII | 71 | Q9H0U4 | |
| RTITSTYYRGTHGVI | 71 | Q15286 | |
| DYTYSTVPRRCGGSH | 1546 | Q9H0J4 | |
| CGGSHTLTYPYHRSR | 1556 | Q9H0J4 | |
| GTYRCYGSVTHSPYQ | 96 | P43631 | |
| PAGSATYREFVHRGY | 21 | Q9BRQ5 | |
| SLTGYRTYRCAHPLA | 301 | Q8IWT6 | |
| GSIDHVYTGSGYRIR | 16 | Q5SQ80 | |
| RPGESSYSSISHVIY | 186 | Q96SQ7 | |
| RRIYSFYSSLGCGHS | 421 | P0C881 | |
| RRIYSFYSSLGCGHS | 421 | B2RC85 | |
| RSLGYHGSSYSPEGV | 2036 | Q9Y618 | |
| FTYVGGPRSVSYSVH | 41 | Q8N3A8 | |
| YGTHVGYSSSREITE | 291 | Q8WWA0 | |
| GTYRCYGSVTHSPYQ | 96 | P43627 | |
| TLSPVSRSYGGQYRC | 281 | P59901 | |
| TSAHAGTYRCYGSRS | 386 | P59901 | |
| FSGRHYIPTDSEGRY | 81 | Q96MP8 | |
| HLYTYTAPAALGSTG | 1101 | Q9H2X6 | |
| YSTRYSTQVSHIGPG | 56 | Q3ZCV2 | |
| GTYRCYGSVTHSPYQ | 96 | P43628 | |
| IDYSRGSIYHSVEGP | 1426 | Q2LD37 | |
| PAGYYIDRDSGTCHS | 606 | Q6UXG2 | |
| YCYRGTGAAVSTRPG | 816 | O15054 | |
| DRRYSHSLYSEGTPG | 271 | Q08397 | |
| GTYRCYGSVTHTPYQ | 191 | P43629 | |
| ATCGRSDTYYQSPTG | 26 | Q9UIS9 | |
| YRSQSPHYFRSGRGE | 1031 | Q9UKJ3 | |
| YRTGRTLHGQETYTP | 51 | Q9BUK6 | |
| RTLGHYRGYCSNVDP | 446 | P11678 | |
| VDGGRSLYTHSYEVP | 261 | Q9BY49 | |
| GTYRCFGSVTHLPYE | 191 | Q8N743 | |
| VTSAHAGTYRCYGSL | 386 | Q8N423 | |
| SPGSGTYTRHGYIFS | 21 | Q9Y3B2 | |
| TPACAGGRSVYTEAY | 146 | Q8TAD2 | |
| VRLGHYSLSPVYESG | 116 | Q9Y337 | |
| YPAGSTIYRHRDLAG | 4791 | P98088 | |
| LGVSYSHSSCGPSYG | 86 | P49639 | |
| PTRGSARAAGYDLYS | 126 | P33316 | |
| GSSPYTSSRCRRELY | 566 | Q8IZL8 | |
| FRPVSASSYLGSTGY | 601 | Q96M63 | |
| PSDGVSDSHRVYSGY | 841 | Q8ND30 | |
| SDSHRVYSGYRGLSP | 846 | Q8ND30 | |
| GPRTPSECSYYSSRI | 216 | Q9Y608 | |
| GTYRCYGSVTHSPYQ | 96 | Q14953 | |
| LYSRDGHSPGTLGVY | 106 | Q92729 | |
| RDGSGLTYIYPGTSH | 216 | Q99489 | |
| PSGCYTYQVSRHSTE | 11 | Q9HBE1 | |
| GSIDHVYTGSGYRIR | 16 | Q5VUR7 | |
| RSGDVYGYSSCTANP | 66 | Q8IV32 | |
| ECHTPSTDTRYLGSY | 126 | Q969P0 | |
| HYFRYLGSLTTPTCD | 216 | P22748 | |
| DPRSYHTYGRTSAAA | 876 | Q8NF50 | |
| HYGSVVTYRCNPGSG | 186 | P17927 | |
| HYGSVVTYRCNPGSG | 636 | P17927 | |
| SRYRVTYSSPEDGIH | 1751 | P02751 | |
| GYDLRGSTYLHCTPQ | 321 | Q2VPA4 | |
| LRISTASGDGRHYCY | 346 | P63092 | |
| HPTFSIYARGRYSRG | 336 | Q8J025 | |
| YSGKSQHSTPSRGRY | 696 | Q9NYL2 | |
| REICPAGHGYTYASS | 721 | Q14767 | |
| YTSDSEVYTDHGRPG | 1316 | Q92538 | |
| SSRSCGGYLHYPASS | 11 | Q8IUC0 | |
| YSRYGRCTGHSSYIT | 711 | Q9HC35 | |
| ATHTIGYGTTRGYRD | 621 | Q9NZU1 | |
| SPCERKGRSYGSYNT | 586 | O00237 | |
| TPGYSTSGHVELYTI | 1166 | A3KN83 | |
| GTYRCYGSVTHSPYQ | 96 | P43626 | |
| CGSSTGAVTSGHYPY | 41 | A0A075B6I9 | |
| PVSRSYGGQYTCSGA | 286 | Q8N6C8 | |
| PVTSAHAGTYRCYGS | 386 | Q8N6C8 | |
| HAGTYRCYGSLSSNP | 391 | Q8N6C8 | |
| GTYVFSYHITVRGRP | 386 | A6NHN0 | |
| VSAYSSTYHRAGCKP | 541 | Q9BZF2 | |
| GTYRCYGSVTHSPYQ | 96 | Q14954 | |
| SYGVLSYHVSGIGTR | 176 | A2VDJ0 | |
| PVSRSYGGQYRCSGA | 286 | O75019 | |
| PVTSAHSGTYRCYGS | 386 | O75019 | |
| HSGTYRCYGSLSSNP | 391 | O75019 | |
| PVTSAHAGTYRCYGS | 386 | Q8NHL6 | |
| HAGTYRCYGSQSSKP | 391 | Q8NHL6 | |
| GTYRCYGSVTHTPYQ | 191 | Q14943 | |
| GCYGDRSSLPGVRSY | 226 | O14594 | |
| YSGTVRGHIYNSTSR | 391 | O75592 | |
| YKPAAGHSSYSVGRA | 26 | Q8NG41 | |
| PARRQDSSGSSGSYY | 21 | E7EW31 | |
| PREHQTGSARSEGYY | 1486 | O15047 | |
| SHGTILYIYCRPSSG | 251 | Q8NGL0 | |
| YYTHLGAGPSVAAVR | 1436 | Q8NFU7 | |
| YRHLAAATPVGSSYG | 1141 | Q14865 | |
| SERSYGSRNGGIPHY | 836 | Q7Z460 | |
| HTDSSTYRIVPGGYA | 486 | P51788 | |
| GDGTHSSAYCPDYTV | 616 | Q8NE01 | |
| EETSRYLDGYCPSGS | 156 | Q68D42 | |
| AYSRDHSPKAYSGGR | 356 | Q8N7X1 | |
| GYPHIRYISSGLDGT | 856 | Q6ZNA4 | |
| GSGCRVSYERHPSQY | 471 | Q13905 | |
| HDGSSRYGPRTYGTT | 191 | Q9C0C2 | |
| SLYASSPGGVYATRS | 51 | P08670 | |
| YRGRVRASYDTGSHP | 1211 | O94813 | |
| AHGYPDLSTTYCGSA | 161 | Q9BXA6 | |
| GISCSRYYPTGTHAK | 541 | O15041 | |
| GSVSNYPRYTGSRSC | 66 | Q6ZVU0 | |
| YGYCSGGSRSRIPHS | 166 | Q9BXE9 | |
| DYEYGSRGPLTACSG | 341 | Q66K66 |